Journal of market access & health policy

Keyphrases

Publications

volume 12, number 1, 2024

Clàudia Aunós
Publisher's Note: A New Chapter for the Journal of Market Access and Health Policy ( JMAHP )-Continued Publication by MDPI. Journal of market access & health policy 12 (1) (2024)
Thomas Desmet, Elaine Julian, Walter Van Dyck, Isabelle Huys, Steven R A Simoens, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter G M Mol, Anja Schiel, Wim G Goettsch, Hendrika van den Ham, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales, Jörg Ruof
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators. Journal of market access & health policy 12 (1) (2024)
Clàudia Aunós
Publisher's Note: A New Chapter for the Journal of Market Access and Health Policy ( JMAHP )-Continued Publication by MDPI. Journal of market access & health policy 12 (1) (2024)
Thomas Desmet, Elaine Julian, Walter Van Dyck, Isabelle Huys, Steven R A Simoens, Rosa Giuliani, Mondher Toumi, Christian Dierks, Juliana Dierks, Antonella Cardone, Francois Houÿez, Mira Pavlovic, Michael Berntgen, Peter G M Mol, Anja Schiel, Wim G Goettsch, Hendrika van den Ham, Stefano Capri, James Ryan, Pierre Ducournau, Oriol Solà-Morales, Jörg Ruof
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators. Journal of market access & health policy 12 (1) (2024)
Matthias Brunner, Manjula Schou, Robert J Briggs, Dell Kingsford Smith
Comparative Clinical Effectiveness and Cost-Effectiveness of the Cochlear Osia System and Baha Attract System in Patients with Conductive or Mixed Hearing Loss or Single-Sided Deafness. Journal of market access & health policy 12 (1) (2024)
Matthias Brunner, Manjula Schou, Robert J Briggs, Dell Kingsford Smith
Comparative Clinical Effectiveness and Cost-Effectiveness of the Cochlear Osia System and Baha Attract System in Patients with Conductive or Mixed Hearing Loss or Single-Sided Deafness. Journal of market access & health policy 12 (1) (2024)
Mondher Toumi
Welcome to the Journal of Market Access and Health Policy under MDPI Wings. Journal of market access & health policy 12 (1) (2024)

volume 12, number 2, 2024

Michal Pochopien, Jakub Wladyslaw Dziedzic, Samuel Aballea, Emilie Clay, Iwona Zerda, Mondher Toumi, Borislav Borissov
Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease. Journal of market access & health policy 12 (2) (2024)
Clara Fatoye, Gillian Yeowell, Eula Miller, Isaac Odeyemi, Chidozie Emmanuel Mbada
Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review. Journal of market access & health policy 12 (2) (2024)
Katia Thokagevistk, Céline Coppo, Laetitia Rey, Amanda Carelli, Veronica Díez, Sarah Vaselenak, Liana Oliveira, Ajay Patel, Emilia Sicari, Teresa Ramos, Susanne Schach, Erika Schirghuber, Alex Simpson, Remy Choquet, Katell Le Lay
Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance. Journal of market access & health policy 12 (2) (2024)
Volker Schuster
EU HTA Regulation and Joint Clinical Assessment-Threat or Opportunity? Journal of market access & health policy 12 (2) (2024)
Bérengère Macabeo, Arthur Quenéchdu, Samuel Aballéa, Clément François, Laurent Boyer, Philippe Laramée
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review. Journal of market access & health policy 12 (2) (2024)
Michal Pochopien, Jakub Wladyslaw Dziedzic, Samuel Aballea, Emilie Clay, Iwona Zerda, Mondher Toumi, Borislav Borissov
Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease. Journal of market access & health policy 12 (2) (2024)
Katia Thokagevistk, Céline Coppo, Laetitia Rey, Amanda Carelli, Veronica Díez, Sarah Vaselenak, Liana Oliveira, Ajay Patel, Emilia Sicari, Teresa Ramos, Susanne Schach, Erika Schirghuber, Alex Simpson, Remy Choquet, Katell Le Lay
Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance. Journal of market access & health policy 12 (2) (2024)
Akihisa Nakamura, Eiji Satoh, Tatsuya Suzuki, Soichi Koike, Kazuhiko Kotani
Future Possible Changes in Medically Underserved Areas in Japan: A Geographic Information System-Based Simulation Study. Journal of market access & health policy 12 (2) (2024)
Clara Fatoye, Gillian Yeowell, Eula Miller, Isaac Odeyemi, Chidozie Emmanuel Mbada
Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review. Journal of market access & health policy 12 (2) (2024)
Akihisa Nakamura, Eiji Satoh, Tatsuya Suzuki, Soichi Koike, Kazuhiko Kotani
Future Possible Changes in Medically Underserved Areas in Japan: A Geographic Information System-Based Simulation Study. Journal of market access & health policy 12 (2) (2024)
Bérengère Macabeo, Arthur Quenéchdu, Samuel Aballéa, Clément François, Laurent Boyer, Philippe Laramée
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review. Journal of market access & health policy 12 (2) (2024)

volume 12, number 3, 2024

Mark Nuijten, Stefano Capri
Valuation of Medical Innovation Handling with Uncertainty and Risk. Journal of market access & health policy 12 (3) (2024)
Francis Fatoye, Francis Fatoye, Leo M Nherera, Paul Trueman
Adoption of a Societal Perspective in Economic Evaluations of Musculoskeletal Disorders: A Conceptual Paper. Journal of market access & health policy 12 (3) (2024)
Portia Lagmay-Fuentes, Andrea Smith, Shannon Krus, Laurie Lewis, Asma Latif, Tiffany Gagliardo, Manpreet Kohli
Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia. Journal of market access & health policy 12 (3) (2024)
Fredy G Rodríguez-Páez, Diego Cabrera-Moya, Jorge Aurelio Herrera-Cuartas
Proposal of a Knowledge Management Model for Complex Systems: Case of the Supervision and Control Subsystem of the Colombian Health System. Journal of market access & health policy 12 (3) (2024)
Portia Lagmay-Fuentes, Andrea Smith, Shannon Krus, Laurie Lewis, Asma Latif, Tiffany Gagliardo, Manpreet Kohli
Expanding the Availability of Scalp Cooling to All Patients at Risk of Chemotherapy-Induced Alopecia. Journal of market access & health policy 12 (3) (2024)
Elaine Julian, Oriol Solà-Morales, Maria João Garcia, Francine Brinkhuis, Mira Pavlovic, Carlos Martín-Saborido, Robin Doeswijk, Rosa Giuliani, Anne Willemsen, Wim Goettsch, Bernhard Wörmann, Urania Dafni, Heiner C Bucher, Begoña Pérez-Valderrama, Renato Bernardini, Fabrizio Gianfrate, Carin Uyl-de Groot, Jörg Ruof
The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy. Journal of market access & health policy 12 (3) (2024)
Khalid Hasan, Shahin Kayum
Patient Experience and Satisfaction with Orthopedic Services at a Community (Rural) Setting Hospital-How Is It Different from Urban Setting. Journal of market access & health policy 12 (3) (2024)
Zilke Claessens, Michiel Lammens, Liese Barbier, Isabelle Huys
Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa Initiative. Journal of market access & health policy 12 (3) (2024)
Zilke Claessens, Michiel Lammens, Liese Barbier, Isabelle Huys
Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa Initiative. Journal of market access & health policy 12 (3) (2024)
Michael Ingham, Hela Romdhani, Aarti Patel, Veronica Ashton, Gabrielle Caron-Lapointe, Anabelle Tardif-Samson, Patrick Lefebvre, Marie-Hélène Lafeuille
Non-Medical Switching or Discontinuation Patterns among Patients with Non-Valvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States: A Claims-Based Analysis. Journal of market access & health policy 12 (3) (2024)
Fredy G Rodríguez-Páez, Diego Cabrera-Moya, Jorge Aurelio Herrera-Cuartas
Proposal of a Knowledge Management Model for Complex Systems: Case of the Supervision and Control Subsystem of the Colombian Health System. Journal of market access & health policy 12 (3) (2024)
Francis Fatoye, Francis Fatoye, Leo M Nherera, Paul Trueman
Adoption of a Societal Perspective in Economic Evaluations of Musculoskeletal Disorders: A Conceptual Paper. Journal of market access & health policy 12 (3) (2024)
Rimma Velikanova, Sharon Wolters, Hinko S Hofstra, Maarten J Postma, Cornelis Boersma
Market Access Challenges and Solutions in Cell and Gene Therapy in The Netherlands. Journal of market access & health policy 12 (3) (2024)
Rimma Velikanova, Sharon Wolters, Hinko S Hofstra, Maarten J Postma, Cornelis Boersma
Market Access Challenges and Solutions in Cell and Gene Therapy in The Netherlands. Journal of market access & health policy 12 (3) (2024)
Mark Nuijten, Stefano Capri
Valuation of Medical Innovation Handling with Uncertainty and Risk. Journal of market access & health policy 12 (3) (2024)
Baudouin Standaert, Désirée Vandenberghe, Mark P Connolly, Johan Hellings
The Knowledge and Application of Economics in Healthcare in a High-Income Country Today: The Case of Belgium. Journal of market access & health policy 12 (3) (2024)
David Cherney, Kerstin Folkerts, Paul Mernagh, Mateusz Nikodem, Joerg Pawlitschko, Peter Rossing, Neil Hawkins
Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison. Journal of market access & health policy 12 (3) (2024)
David Cherney, Kerstin Folkerts, Paul Mernagh, Mateusz Nikodem, Joerg Pawlitschko, Peter Rossing, Neil Hawkins
Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison. Journal of market access & health policy 12 (3) (2024)
Khalid Hasan, Shahin Kayum
Patient Experience and Satisfaction with Orthopedic Services at a Community (Rural) Setting Hospital-How Is It Different from Urban Setting. Journal of market access & health policy 12 (3) (2024)
Elaine Julian, Oriol Solà-Morales, Maria João Garcia, Francine Brinkhuis, Mira Pavlovic, Carlos Martín-Saborido, Robin Doeswijk, Rosa Giuliani, Anne Willemsen, Wim Goettsch, Bernhard Wörmann, Urania Dafni, Heiner C Bucher, Begoña Pérez-Valderrama, Renato Bernardini, Fabrizio Gianfrate, Carin Uyl-de Groot, Jörg Ruof
The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy. Journal of market access & health policy 12 (3) (2024)

volume 11, number 1, 2023

Aino Vesikansa, Juha Mehtälä, Katja Mutanen, Annamari Lundqvist, Tiina Laatikainen, Tero Ylisaukko-Oja, Tero Saukkonen, Kirsi H Pietiläinen
The association between body mass index groups and metabolic comorbidities with healthcare and medication costs: a nationwide biobank and registry study in Finland. Journal of market access & health policy 11 (1) (2023)
Masafumi Kato, Mariko Yoneyama-Hirozane, Katsuhiko Iwasaki, Mao Matsubayashi, Ataru Igarashi
Health-related quality of life in health states corresponding to different stages of perianal fistula associated with Crohn's disease: a quantitative evaluation of patients and non-patients in Japan. Journal of market access & health policy 11 (1) (2023)
Niamh Carey, Joy Leahy, Lea Trela-Larsen, Laura Mc Cullagh, Michael Barry
Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare setting. Journal of market access & health policy 11 (1) (2023)
Chee Yoong Foo, Nurul Azwani Nadia Mansor, Shereen Suyin Ch'ng, Mollyza Mohd Zain
Projecting direct medical costs and productivity benefits of improving access to advanced therapy for rheumatoid arthritis: a projection modelling study. Journal of market access & health policy 11 (1) (2023)
Dimika Cavalier, Bridget Doherty, Gabrielle Geonnotti, Aarti Patel, Wesley Peters, Steven Zona, Lisa Shea
Patient perceptions of copay card utilization and policies. Journal of market access & health policy 11 (1) (2023)
Tanja Fens, Lisa Aniek de Jong, Bregt Kappelhoff, Cornelis Boersma, Maarten Jacobus Postma
Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran. Journal of market access & health policy 11 (1) (2023)
A Aiello, E E Mariano, M Prada, L Cioni, C Teruzzi, R Manna
Budget impact analysis of anakinra in the treatment of familial Mediterranean fever in Italy. Journal of market access & health policy 11 (1) (2023)
Beata Smela, Mondher Toumi, Karolina Świerk, Clement Francois, Małgorzata Biernikiewicz, Emilie Clay, Laurent Boyer
Rapid literature review: definition and methodology. Journal of market access & health policy 11 (1) (2023)
Hajer Dahmani, Ines Fradi, Leila Achour, Mondher Toumi, null null
Pharmaceutical pricing and reimbursement policies in Algeria, Morocco, and Tunisia: comparative analysis. Journal of market access & health policy 11 (1) (2023)
Leila Achour, Chema Drira, Mohamed Zied Sboui, Ikram Fazaa, Mohamed Ali Soussi, Senda Hammami, Tarek Ben Othman, Myriam Razgallah Khrouf
Economic analysis of allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Center of Tunisia. Journal of market access & health policy 11 (1) (2023)
Chee Yoong Foo, Nurul Azwani Nadia Mansor, Shereen Suyin Ch'ng, Mollyza Mohd Zain
Projecting direct medical costs and productivity benefits of improving access to advanced therapy for rheumatoid arthritis: a projection modelling study. Journal of market access & health policy 11 (1) (2023)
Beata Smela, Mondher Toumi, Karolina Świerk, Konrad Gawlik, Emilie Clay, Laurent Boyer
Systematic literature reviews over the years. Journal of market access & health policy 11 (1) (2023)